Substituted piperidine as a novel lead molecule for the treatment of Parkinson's disease: Synthesis, crystal structure, hirshfeld surface analysis, and molecular modeling
JOURNAL OF MOLECULAR STRUCTURE, cilt.1265, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 1265
- Basım Tarihi: 2022
- Doi Numarası: 10.1016/j.molstruc.2022.133350
- Dergi Adı: JOURNAL OF MOLECULAR STRUCTURE
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Chemical Abstracts Core, INSPEC
- Anahtar Kelimeler: oxidase B inhibition, Molecular docking, Hirshfeld surface, Carboxylate, MONOAMINE-OXIDASE, DERIVATIVES, INHIBITORS, ISOFORMS, ANALOGS
- Hacettepe Üniversitesi Adresli: Evet
Özet
The current research outlines the synthesis of benzyl 4- (4-chlorophenylamino) -1-(4-chlorophenyl) -2,6bis(4-chlorophenyl) -1,2,5,6-tetrahydropyridine -3-carboxylate. The title compound was crystallized in the monoclinic space group P21/n with Z = 4 and unit cell parameters a = 13.6684 A (8), b = 9.1256 A (4), c = 14.0839 A (8), = 111.168 (7) degrees, and V = 1638.18 (17) degrees. The six-membered non-planar ring is shaped like a boat. Intermolecular C-H middotmiddotmiddotCl hydrogen bonds connect molecules in a three-dimensional crystal framework. The most significant contributions to crystal packing, according to the Hirshfeld surface investigation of the crystal structure, are from H middotmiddotmiddot H (35.3%), H... Cl/Cl... H (27.0%), and H middotmiddotmiddot C/C middotmiddotmiddot H (21.8%). As a result, van der Waals interactions take precedence in crystal packing. In-vitro studies suggested this compound has better IC 50 value of 0.588 +/- 0.09 mu M against MAO-A. In silico investigations, such as molecular docking, demonstrated that this molecule possessed exceptionally high Monoamine Oxidase A and Monoamine Oxidase B activity, with a binding energy value of -32.504 kJ/mol. Furthermore, Density functional theory (DFT) analyses supported these findings and suggested derivative 4 as a potential 'lead' molecule in pharmaceutical discovery and development.(c) 2022 Elsevier B.V. All rights reserved.